| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 03/10/2024 | 14:00 | GlobeNewswire Inc. | Harvard Bioscience to Showcase Innovative Technologies at Society for Neuroscience (SfN) Annual Meeting 2024 | NASDAQ:HBIO | Harvard Bioscience Inc |
| 18/09/2024 | 13:30 | GlobeNewswire Inc. | Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Safety Pharmacology Society Annual Meeting | NASDAQ:HBIO | Harvard Bioscience Inc |
| 05/09/2024 | 22:05 | GlobeNewswire Inc. | Harvard Bioscience, Inc. to Participate in the Sidoti Small Cap Virtual Conference | NASDAQ:HBIO | Harvard Bioscience Inc |
| 08/08/2024 | 15:00 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:HBIO | Harvard Bioscience Inc |
| 08/08/2024 | 14:30 | GlobeNewswire Inc. | Harvard Bioscience Announces Second Quarter 2024 Financial Results | NASDAQ:HBIO | Harvard Bioscience Inc |
| 08/08/2024 | 14:29 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:HBIO | Harvard Bioscience Inc |
| 02/08/2024 | 14:00 | GlobeNewswire Inc. | Harvard Bioscience Schedules Second Quarter 2024 Earnings Conference Call for August 8, 2024 at 10:00 AM ET | NASDAQ:HBIO | Harvard Bioscience Inc |
| 14/06/2024 | 22:02 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:HBIO | Harvard Bioscience Inc |
| 06/06/2024 | 22:05 | GlobeNewswire Inc. | Harvard Bioscience, Inc. to Present and Host One-on-One Meetings at the 14th Annual East Coast IDEAS Conference on June 12, 2024 | NASDAQ:HBIO | Harvard Bioscience Inc |
| 29/05/2024 | 23:01 | Edgar (US Regulatory) | Form SD - Specialized disclosure report | NASDAQ:HBIO | Harvard Bioscience Inc |
| 23/05/2024 | 22:05 | GlobeNewswire Inc. | Harvard Bioscience, Inc. to Present at the Jefferies Global Healthcare Conference on June 5, 2024 | NASDAQ:HBIO | Harvard Bioscience Inc |
| 16/05/2024 | 22:05 | GlobeNewswire Inc. | Harvard Bioscience, Inc. to Participate in the Benchmark Healthcare House Call Virtual Conference | NASDAQ:HBIO | Harvard Bioscience Inc |
| 07/05/2024 | 13:00 | GlobeNewswire Inc. | Harvard Bioscience Announces First Quarter 2024 Financial Results | NASDAQ:HBIO | Harvard Bioscience Inc |
| 29/04/2024 | 14:45 | GlobeNewswire Inc. | Harvard Bioscience Schedules First Quarter 2024 Earnings Conference Call for May 7, 2024 at 8:00 AM ET | NASDAQ:HBIO | Harvard Bioscience Inc |
| 09/04/2024 | 15:00 | GlobeNewswire Inc. | Harvard Bioscience Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth | NASDAQ:HBIO | Harvard Bioscience Inc |
| 11/03/2024 | 13:00 | GlobeNewswire Inc. | Harvard Bioscience, Inc. to Participate in March 2024 Investor Conferences: Sidoti’s Small Cap Conference and KeyBanc’s Life Sciences & MedTech Conference | NASDAQ:HBIO | Harvard Bioscience Inc |
| 07/03/2024 | 23:00 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] | NASDAQ:HBIO | Harvard Bioscience Inc |
| 07/03/2024 | 13:00 | GlobeNewswire Inc. | Harvard Bioscience Announces Fourth Quarter 2023 Financial Results | NASDAQ:HBIO | Harvard Bioscience Inc |
| 06/03/2024 | 14:30 | GlobeNewswire Inc. | Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting | NASDAQ:HBIO | Harvard Bioscience Inc |
| 27/02/2024 | 23:10 | GlobeNewswire Inc. | Harvard Bioscience Schedules Fourth Quarter 2023 Earnings Conference Call for March 7, 2024 at 8:00 AM ET | NASDAQ:HBIO | Harvard Bioscience Inc |
| 14/02/2024 | 22:05 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] | NASDAQ:HBIO | Harvard Bioscience Inc |
| 20/11/2023 | 22:40 | GlobeNewswire Inc. | Harvard Bioscience to Present at Benchmark Company’s Discovery One-On-One Investor Conference on December 7, 2023 | NASDAQ:HBIO | Harvard Bioscience Inc |
| 09/11/2023 | 22:30 | GlobeNewswire Inc. | Harvard Bioscience to Present at Southwest IDEAS Investor Conference on November 16, 2023 | NASDAQ:HBIO | Harvard Bioscience Inc |
| 07/11/2023 | 13:00 | GlobeNewswire Inc. | Harvard Bioscience Announces Third Quarter 2023 Financial Results | NASDAQ:HBIO | Harvard Bioscience Inc |
| 06/11/2023 | 22:30 | GlobeNewswire Inc. | Harvard Bioscience to Showcase Latest Innovations in Preclinical and Organoid Research at Society for Neuroscience Conference on November 12-15, 2023 | NASDAQ:HBIO | Harvard Bioscience Inc |
| 30/10/2023 | 14:00 | GlobeNewswire Inc. | Harvard Bioscience Schedules Third Quarter 2023 Earnings Conference Call for November 7, 2023 at 8:00 AM ET | NASDAQ:HBIO | Harvard Bioscience Inc |
| 18/09/2023 | 14:57 | GlobeNewswire Inc. | Harvard Bioscience and Etisense Announce Agreement for Supply and Distribution of DECRO Miniature Telemetry Jacket Platform for Pre-Clinical Research | NASDAQ:HBIO | Harvard Bioscience Inc |
| 08/08/2023 | 13:18 | GlobeNewswire Inc. | Harvard Bioscience Announces Second Quarter 2023 Financial Results | NASDAQ:HBIO | Harvard Bioscience Inc |
| 04/08/2023 | 00:30 | GlobeNewswire Inc. | Harvard Bioscience to Present at Sidoti Virtual Investor Conference on August 16, 2023 | NASDAQ:HBIO | Harvard Bioscience Inc |
| 28/07/2023 | 00:36 | GlobeNewswire Inc. | Harvard Bioscience Schedules Second Quarter 2023 Earnings Conference Call for August 8, 2023 at 8:00 AM ET | NASDAQ:HBIO | Harvard Bioscience Inc |